At nanoscale, man-made materials may show unique properties that differ from bulk and
dissolved counterparts. The unique properties of engineered nanomaterials not only impart …

RNA-based products have emerged as one of the most promising and strategic
technologies for global vaccination, infectious disease control, and future therapy …

Depending on the context, nanotechnologies developed as nanomedicines (nanosized
therapeutics and imaging agents) are presented as either a remarkable technological …

Herbal remedies were the first medicines used by humans due to the many
pharmacologically active secondary metabolites produced by plants. Some of these …

Quality by Test was the only way to guarantee quality of drug products before FDA launched
current Good Manufacturing Practice. To clearly understand the manufacture processes …

A steady increase of product titers and the corresponding change in impurity composition
represent a challenge for development and optimization of antibody production processes …

The term “polymer therapeutics” was coined to describe polymeric drugs, polymer
conjugates of proteins, drugs and aptamers, together with those block copolymer micelles …

Monoclonal antibodies have proved to be a highly successful class of therapeutic products.
Large‐scale manufacturing of pharmaceutical antibodies is a complex activity that requires …

L-Asparaginase (ASNase) is a vital component of the first line treatment of acute
lymphoblastic leukemia (ALL), an aggressive type of blood cancer expected to afflict over …

Typical bioprocess comprises of different unit operations wherein a near optimal
environment is required for cells to grow, divide, and synthesize the desired product …